Advanced Clinical Research Private Limited

Manages clinical trials for various medical fields, founded in 2004.

2004 | Bangaluru, Karnataka (India) | Active
Last Updated:

Advanced Clinical Research Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 15 Days
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth 13.51%
  • Ebitda -10.46%
  • Net Worth -198.24%
  • Total Assets -31.36%

About Advanced Clinical Research

Advanced Clinical Research Private Limited (ACRPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2004 and has a history of 21 years. Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Preeti Lodha and Sreetama Kar serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U51397KA2004PTC033641

  • Company No.

    033641

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    26 Mar 2004

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Pharma
Company report

Advanced Clinical Research Private Limited

Explore comprehensive data for Advanced Clinical Research Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Advanced Clinical Research?

Board Members (2)

NameDesignationAppointment DateStatus
Preeti Lodha Country flag representing In Director 26-Feb-2021Current
Sreetama Kar Country flag representing In Additional Director 11-Dec-2023Current

Financial Performance of Advanced Clinical Research.

Advanced Clinical Research Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 13.51% increase in profit. The company's net worth observed a substantial decline by a decrease of 198.24%.

Advanced Clinical Research revenue growth over time
Advanced Clinical Research profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-31.36%
Profit or Loss
13.51%
Net Worth
-198.24%
EBITDA
-10.46%

What is the Ownership and Shareholding Structure of Advanced Clinical Research?

In 2022, Advanced Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Advanced Clinical Research?

Unlock and access historical data on people associated with Advanced Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Advanced Clinical Research Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Advanced Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Clinical Research's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Advanced Clinical Research

Recent activity within the organization

  • Director Appointment

    Sreetama Kar was appointed as a Additional Director was appointed as a Additional Director on 11 Dec 2023 & has been associated with this company since 1 year 4 months .

  • Annual General Meeting

    Advanced Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Advanced Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.

  • Director Appointment

    Preeti Lodha was appointed as a Director was appointed as a Director on 26 Feb 2021 & has been associated with this company since 4 years 1 month .

  • Company Incorporation

    Advanced Clinical Research Private Limited was registered on 26 Mar 2004 with Roc Bangalore & aged 21 years 15 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Advanced Clinical Research Private Limited?

    Advanced Clinical Research Private Limited was incorporated on 26 Mar 2004.

  • What is authorized share capital and paid-up capital of Advanced Clinical Research Private Limited?

    The authorized share capital of Advanced Clinical Research Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Advanced Clinical Research Private Limited?

    Currently 2 directors are associated with Advanced Clinical Research Private Limited.

    • Preeti Lodha
    • Sreetama Kar
  • What is the registered address of Advanced Clinical Research Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Advanced Clinical Research Private Limited is No.1156 1St Floor 26Th Main 4Th 'T' Block Jayanagar, India, Bengaluru, Karnataka, 560041.

  • What is the corporate identification number (CIN) and company number of Advanced Clinical Research Private Limited?

    The corporate identification number (CIN) of Advanced Clinical Research Private Limited is U51397KA2004PTC033641 and the company number is 033641 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Advanced Clinical Research Private Limited?

    The Official website of Advanced Clinical Research Private Limited is https://www.advancedcr.net

  • What change has been observed in the net worth of Advanced Clinical Research Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Advanced Clinical Research Private Limited has experienced an downturn of -198.24%.

  • When was the last Balance Sheet of Advanced Clinical Research Private Limited filed with the ROC?

    The most recent Balance Sheet for Advanced Clinical Research Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharma Contract R&D